ResMed Announces Participation in the Bank of America Global Healthcare ConferenceGlobeNewsWire • 09/07/22
ResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 09/06/22
Over 480 Million People Estimated to Have COPD, World's Third Deadliest Disease, ResMed Study ReportsGlobeNewsWire • 09/04/22
Resmed, Inc. (RMD) CEO Michael Farrell on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
ResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnioGlobeNewsWire • 08/02/22
ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software SolutionsGlobeNewsWire • 06/14/22
ResMed: Near-Term Upside From Philips Withdrawal, Seeking $35 Per Share Return ObjectiveSeeking Alpha • 06/07/22
ResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare ConferenceGlobeNewsWire • 06/07/22
ResMed Announces Participation in the 42nd Annual William Blair Growth Stock ConferenceGlobeNewsWire • 06/01/22
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions ConferenceGlobeNewsWire • 05/25/22